Illumina, Inc. vs Mercadolibre Inc — how do they compare? Illumina, Inc. trades at $193.06 (market cap $29.12B), while Mercadolibre Inc trades at $1,930.13 (market cap $98.35B). The key difference: Mercadolibre Inc is far larger — about 3.4× Illumina, Inc.'s market cap, and Mercadolibre Inc is trading nearer its 52-week high, Illumina, Inc. nearer its low. Which is the better fit depends on your goals.
| ILMN | MELI | |
|---|---|---|
Market Cap | $29.12B | $98.35B |
Sector | Health | Consumer Cyclical |
52-Week High | $205.10 | $2.51K |
52-Week Low | $91.00 | $1.55K |
Enterprise Value | $30.48B | $106.00B |
Trailing returns across standard periods
Latest headlines on both assets
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →MercadoLibre runs the largest e-commerce marketplace in Latin America, connecting a network of more than 140 million active users and 1 million active sellers as of the end of 2021 across an 18-country footprint. The company also operates a host of complementary businesses, with shipping solutions (Mercado Envios), a payment and financing operation (Mercado Pago), advertisements (Mercado Clics), classifieds, and a turnkey e-commerce solution (Mercado Shops) rounding out its arsenal. MercadoLibre generates revenue from final value fees, advertising royalties, payment processing, insertion fees, subscription fees, and interest income from consumer and small-business lending.
Read more on MELI →